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The results of prospective, randomized clinical
trials have been used to determine that carotid
endarterectomy is preferable to medical management
for patients with symptomatic high-grade carotid
stenosis.1-3 One of the most widely quoted confir-
mations of this practice guideline remains the North
American Symptomatic Carotid Endarterectomy
Trial (NASCET).1 As a multicenter study, NASCET
included a subset of all symptomatic patients who
presented to a variety of participating centers.
NASCET also included a subset of surgeons who had
a high level of surgical expertise.
These inclusion criteria for patients and surgeons
may have introduced selection bias into the applica-
bility of the NASCET recommendations to a gener-
al community population. For example, NASCET
excluded patients older than 80 years, yet this elder-
ly subset is becoming more prevalent in practice. In
addition, some community and state reports of
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carotid endarterectomy reveal that the average num-
ber of such operations per year per surgeon is
remarkably low and the outcomes vary notably.4
To determine whether the conclusions of
NASCET are applicable to general community prac-
tice, we compared the characteristics and outcomes
of patient enrolled in NASCET with those of all res-
idents of a geographically defined community who
underwent elective carotid endarterectomy for tran-
sient ischemic attacks (TIAs) or nondisabling stroke
between l970 and 1995. Because the initial report of
NASCET had the relatively short follow-up period
of only 18 months, we also used our 25-year data-
base to address the critical issue of durability of the
initial benefit of carotid endarterectomy compared
with that of medical therapy.
METHODS
Source of data. Olmsted County, Minn., pro-
vides a unique database for large-scale population-
based investigations of cerebrovascular disease.5
Virtually all residents of the community receive their
medical care at the Mayo Clinic, Olmsted Medical
Group, or Olmsted Community Hospital. Carotid
operations are performed exclusively at the Mayo
Clinic. A medical record diagnostic indexing system
provides access to the details of all patient encoun-
ters, both inpatient and outpatient, and has support-
ed numerous studies of cardiovascular and other dis-
eases.5 Because all patients who underwent carotid
operation did so at the Mayo Clinic, their early and
late postoperative care also was conducted exclusive-
ly at the Mayo Clinic. This study was reviewed and
approved by the Mayo Institutional Review Board.
Carotid endarterectomy cohort. All 297
Olmsted County residents who underwent an initial
elective carotid endarterectomy between l970 and
l995, inclusive, were identified. Preoperative indica-
tion for operation was classified as either sympto-
matic (TIAs or nondisabling stroke) or asympto-
matic high-grade stenosis. Only patients with ather-
osclerotic carotid disease were included, and any
patients who underwent an emergency carotid
endarterectomy was excluded.
Data collection. Data abstracted from the med-
ical records of the subset of patients with cere-
brovascular symptoms specific to the carotid distrib-
ution of the endarterectomy included age, gender,
type of symptom (TIA or stroke), signs of clinically
evident coronary artery disease (CAD) (angina pec-
toris, previous myocardial infarction, congestive
heart failure, previous coronary revascularization,
and positive noninvasive tests for ischemia), and the
presence of hypertension or diabetes mellitus. End
points referable to neurologic events, vital status,
and cause of death were recorded. Data from this
review were transcribed into an on-line computer
data entry system and edited with various range and
consistency checks. These data from Olmsted
County, Minn., were compared with those from
NASCET.1
Follow-up. One hundred percent follow-up
through Feb. 20, l997, for neurologic events and
death was achieved through scrutiny of the entire
community-wide medical record information for
each patient.
Statistical methods. The Kaplan-Meier method
was used to estimate the probability of survival or
survival free of a neurologic event after carotid
endarterectomy.6 Survivorship curves were com-
pared with log-rank tests.7 Expected survival rates
for the age-matched and gender-matched 1980 white
Minnesota population were used for comparison.
RESULTS
Patient characteristics. Of the 297 patients
undergoing elective carotid endarterectomy
between l970 and 1995, TIAs or nondisabling
stroke was the surgical indication in 254 patients
(86%), whereas the remaining 14% had asympto-
matic high-grade stenosis. This cohort of 254 symp-
tomatic patients included 65% men and 35% women
with a median age of 67 years (range, 47 to 87
years). Compared with the demographic characteris-
tics of the NASCET participants, the Olmsted
County carotid endarterectomy cohort was remark-
ably similar (Table I).
Specifically, mean age and gender distribution
were essentially the same for the two groups with the
exception that the Olmsted County cohort included
26 patients (10%) who were older than 80 years,
which was an exclusion criterion for NASCET. The
Olmsted County and NASCET indications for
carotid operation were TIAs in the majority of
patients (69% versus 67%, respectively) and nondis-
abling stroke in the remainder (31% versus 33%,
respectively). The prevalence rates of medical
comorbidity for the current population-based study
and NASCET also were similar (Table I). Clinically
evident CAD was common (42% versus 40%, respec-
tively), as were hypertension (55% versus 60%,
respectively) and diabetes mellitus (20% versus 17%,
respectively).
Perioperative morbidity and mortality rates.
The 30-day mortality rate was 1.6% for the entire
25-year period (1970 through 1995) for Olmsted
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County patients compared with 0.6% for NASCET
patients between l988 and 1991. Stroke in any cere-
bral distribution affected 3.9% of Olmsted County
patients within 30 days of endarterectomy (ipsilater-
al stroke, 3.4%) compared with 2.1% of NASCET
patients. The 30-day mortality rate for stroke was
5.1% for Olmsted County patients compared with
5.8% for NASCET patients (not significant).
In the subset of 26 patients who were older than
80 years, there were no deaths by 30 days.
However, five patients had a perioperative stroke
(19.2% compared with 2.2% for patients younger
than 80 years, p = 0.001). These five strokes
accounted for 50% of the perioperative strokes that
occurred in the entire cohort. The indication for
endarterectomy (stroke versus TIA) did not differ
for patients older versus those younger than 80
years; however, nearly half of the octogenarians had
their perioperative stroke after hospital discharge
and in a cerebral territory remote from the carotid
endarterectomy.
Long-term neurologic event outcome. Late
follow-up averaged 4.3 years (range, 0 to 15.6 years)
in Olmsted County compared with only 1.5 years
for NASCET. The cumulative probability of ipsilat-
eral stroke at 2 years after carotid endarterectomy in
Olmsted County was 4.1% (95% confidence interval
[CI], 1.6% to 6.5%) compared with 9.0% for
NASCET (Fig. 1). At later follow-up in this current
population-based study, survival free of ipsilateral
stroke was 93% (95% CI, 90% to 97%) at 5 years and
92% (95% CI, 87% to 97%) at 10 years.
The cumulative probability of stroke in any cere-
bral territory was 7.0% (95% CI, 3.7% to 10.2%) at 2
years after carotid endarterectomy in Olmsted
County compared with 12.6% for NASCET. At later
follow-up in Olmsted County, the rate for survival
free of any stroke was 90% (95% CI, 85% to 94%) at
5 years and 80% (95% CI, 72% to 90%) at 10 years
(Fig. 2).
When survival to any TIA or stroke in any cere-
bral distribution was considered, the Kaplan-Meier
survival estimates were 88% (95% CI, 84% to 92%) at
2 years, 82% (95% CI, 77% to 88%) at 5 years, and
64% (95% CI, 52% to 79%) at 10 years. NASCET
has not reported survival estimates for late TIA or
stroke.
Relation of risk factors to neurologic events.
There was a trend toward the presence of hyperten-
sion adversely influencing the late cumulative inci-
dence of TIAs or stroke. The cumulative incidence
for hypertension versus normotension was 26% ver-
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Table I. Comparison of patient characteristics of
NASCET and Olmsted County, Minn., for 1970
through 1995
NASCET Olmsted County, 
(n = 328) Minn. (n = 254)
Characteristic Percent of group




TIA at entry 67 69
Stroke at entry 33 31
Clinically evident CAD* 40 43
Hypertension 60 55
Diabetes mellitus 17 21
*Clinically evident CAD (e.g., angina pectoris, previous myocar-
dial infarction).
Fig. 1. Rates of survival free of ipsilateral stroke after
elective carotid endarterectomy for TIAs or nondisabling
stroke for NASCET1 and Olmsted County, Minn., for
1970 through 1995. Deaths have been censored. The
number of patients available for observation was 254 at
onset and 82 at 5 years.
Fig. 2. Rates of survival free of any stroke for NASCET1
and Olmsted County, Minn., for 1970 through 1995.
Deaths have been censored. The number of patients for
observation was 254 at onset and 80 at 5 years.
sus 11% (p = 0.18). Neither diabetes mellitus nor
clinically evident CAD showed a significant effect on
the occurrence of late neurologic events. NASCET
reported that the number of medical risk factors
influenced the incidence of ipsilateral stroke in med-
ically treated patients within 2 years. However, the
prognosis of surgically treated patients did not vary
significantly among risk groups and was 9% at 2
years. NASCET has not published an analysis of the
impact of risk factor on late neurologic events.
Long-term survival. By the end of the follow-
up period, 68 of the 254 patients (27%) who under-
went carotid endarterectomy in Olmsted County
had died. The overall Kaplan-Meier estimate of the
probability of survival was 73% (95% CI, 66% to
80%) at 5 years and 55% (95% CI, 44% to 65%) at 10
years, a significantly poorer rate than the expected
survival rates of 85% and 68% (with reference to the
age-and gender-adjusted 1980 Minnesota white
population, p = 0.0001) (Fig. 3). Comparable esti-
mates have not been reported by NASCET.
Cardiac events accounted for 32 of the 68 deaths
(47%) in Olmsted County patients after carotid
endarterectomy and represented the most common
cause of late mortality (Table II). Stroke was record-
ed as the primary cause of late death in only seven
patients (10%). Similarly, one third of the deaths of
the surgical patients in NASCET were attributed to
myocardial infarction or other ischemic heart dis-
ease, whereas stroke accounted for 13% of deaths.
Relation of risk factors to late survival. The
presence of diabetes mellitus had the greatest impact
of any medical comorbidity on late survival after
carotid endarterectomy in Olmsted County patients
(Fig. 4). Overall survival rates decreased significant-
ly in patients with diabetes compared with patients
without diabetes (p = 0.0008). The 8-year survival
rate was only 27% (95% CI, 12% to 60%) for patients
with diabetes compared with 67% (95% CI, 58% to
78%) for those without diabetes (p = 0.002). The
presence of clinically evident CAD was associated
with a trend toward a decreasing 5-year survival rate
of 63% (95% CI, 52% to 75%) compared with 81%
(95% CI, 74% to 89%) for no evidence of CAD (p =
0.0378) (Fig. 5). Hypertension did not demonstrate
a significant impact on late survival rates.
DISCUSSION
This population-based study of elective carotid
endarterectomy for symptomatic patients confirms
the early beneficial results reported by NASCET and
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Fig. 3. Rates of survival after elective carotid endarterec-
tomy for TIAs or nondisabling stroke for Olmsted
County, Minn., for 1970 through 1995. The number of
patients remaining for observation at 5 and 10 years was
88 and 18, respectively.
Fig. 4. Impact of diabetes mellitus on survival after elec-
tive carotid endarterectomy for Olmsted County, Minn.,
for 1970 through 1995. The number of patients remain-
ing for observation at 5 and 10 years was 75 and 16,
respectively, for patients without diabetes and 12 and 2,
respectively, for patients with diabetes.
Table II. Total mortality rates for residents of
Olmsted County, Minn., after carotid endarterecto-
my in symptomatic patients for 1970 through 1995




Pulmonary embolus 3 (4)




other clinical trials.1-3 The benefits of our study
occurred in a geographically defined community in
which all patients undergoing carotid operation
were included and a variety of vascular and neuro-
logic surgeons performed the operation. In addi-
tion, our study exceeded the short follow-up of
NASCET and added long-term confirmation that
carotid endarterectomy minimized subsequent
stroke. Two additional findings from our analysis
deserve emphasis. More than any other risk factor,
hypertension showed a trend toward increasing the
late risk of TIAs or stroke after carotid operation.
Second, diabetes mellitus and clinically evident CAD
dramatically reduced late survival rates.
The interpretation of our comparison of Olmsted
County results with those of NASCET must address
the differences and similarities of the two groups.
First, NASCET was a prospective, randomized trial
that involved 50 medical centers. Our study was a
retrospective, population-based analysis of one com-
munity and one medical center. Nevertheless, com-
parability was striking. The two patient cohorts were
comparable in age, gender, neurologic indication for
operation, and risk factors. Only a small fraction
(10%) of the Olmsted County cohort was older than
80 years, an exclusion criterion for NASCET.
Likewise, both studies were conducted in centers in
which the combined perioperative stroke and mortal-
ity rate was established to be less than 6%.1,8
Although the Olmsted County study covered a 25-
year period compared with only a 3-year period for
NASCET, we could not identify any major changes
in surgical selection criteria or technique that should
have biased our comparison of the two studies.
In several ways, our population-based analysis
not only reinforces but also extends the risk esti-
mates of stroke and death reported by NASCET.
Until NASCET publishes its late outcomes that
include the impact of risk factors on these results,
the current study provides important data for pre-
dicting late clinical outcomes of carotid endarterec-
tomy. For example, the beneficial results of carotid
endarterectomy persisted for at least 10 years in
Olmsted County residents. The cumulative risk of
ipsilateral stroke rose only slightly from 5% at 2 years
to 8% at 5 and 10% at 10 years after surgical inter-
vention. Because all carotid operation was per-
formed at the Mayo Clinic and the outcomes were
assessed periodically by surgeons, neurologists, and
interns at the clinic, it is unlikely that any early or
late major neurologic events would have gone unde-
tected. In contrast, previous population-based stud-
ies from this same community revealed an estimated
risk of 35% at 5 years for ipsilateral stroke in patients
with TIAs who were treated medically.9
Moreover, the prognostic impact of medical
comorbidity on subsequent neurologic events and
overall survival was confirmed in the later years of
follow-up in the current population-based analysis.
Control of blood pressure appears to be critical in
alleviating stroke risk after carotid endarterectomy, a
finding corroborated with other studies from this
same community in which the role was examined of
hypertension in accelerating the risk of stroke in
medically treated patients.10-12 The size of our cur-
rent study cohort and the small number of late neu-
rologic events may have limited our ability to deter-
mine other definitive relations between risk factors
and stroke. However, in a larger study of 1804 resi-
dents of Rochester, Minn., between l960 and 1973,
the individual relative risks for eventual stroke were
4.0 for hypertension, 2.2 for CAD, and 1.7 for dia-
betes mellitus.10
Two risk factors had notable impacts on late sur-
vival after carotid operation. Within 3 years, the
presence of diabetes mellitus had a profoundly neg-
ative impact on survival rates, whereas clinically evi-
dent CAD showed its most important influence on
worsening survival rates after 4 years. Our previous-
ly reported analysis of l77 carotid endarterectomies
between l970 and 1987 emphasized the importance
of identifying CAD and maximizing its long-term
management.13
The results of both our population-based study
and NASCET must be interpreted with several cau-
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Fig. 5. Impact of clinically evident CAD on survival rates
for Olmsted County, Minn., for 1970 through 1995. The
number of patients remaining for observation at 5 and 10
years was 52 and 13, respectively, for those with evident
CAD and 35 and 5, respectively, for those without evident
CAD.
tions. First, these recommendations apply to sur-
geons whose perioperative stroke and death rates are
less than 5% to 6%. The NASCET collaborators
emphasized that all benefits of carotid endarterecto-
my may be lost if the rate of major complications
approaches 10%.1 Also, these data do not address
whether carotid operation is likely to benefit patients
with (1) more disabling strokes, (2) progressing
strokes in evolution, (3) chronic organ failure (e.g.,
dialysis-dependent chronic renal failure or chronic
congestive heart failure), (4) atrial fibrillation or
other sources of cerebral emboli plus high-grade
carotid stenosis, or (5) diffuse cerebrovascular dis-
ease (e.g., multiple extracranial brachiocephalic
stenoses or intracranial small vessel disease).
In addition, previous randomized trials have not
addressed the increasing issue of whether carotid
endarterectomy benefits the symptomatic patient
who is older than 80 years. In a recent Mayo Clinic
study of 749 carotid endarterectomies in sympto-
matic patients older than 70 years, 56 patients (7%)
were older than 80 years.14 This previous referral-
based study included our larger regional practice,
which attracts patients who are sufficiently healthy
to make the trip to Rochester. Sicker or more debil-
itated patients may not be referred or may choose
not to make the trip. Thus these selected referral
patients are generally better operative risks than
those of our community practice, which includes all
patients regardless of medical comorbidity.
In our previous referral-based study, the combined
perioperative combined stroke and mortality rate was
5.4% for patients older than 80 years.14 These referral
practice results are considerably better than the 19%
perioperative stroke rate observed in the current pop-
ulation-based study. Nearly half of the postoperative
strokes in community octogenarians occurred after
hospital discharge and often in cerebral distributions
unrelated to the carotid endarterectomy. Therefore
one must carefully select symptomatic octogenarians
for carotid endarterectomy. The use of antiplatelet
agents or warfarin anticoagulation may be preferable
to carotid endarterectomy for some symptomatic
octogenarians with serious medical comorbidity.
Currently, it is too early to determine the appropriate
role of carotid stent angioplasty in such patients.
Finally, population-based studies provide a relative-
ly unbiased method to estimate the long-term results
of multicenter, randomized clinical trials, provided the
patient characteristics and management protocols for
the two groups are comparable. Limited by constraints
of accrual time and funding, randomized trials often
have remarkably short follow-up periods (i.e., an aver-
age of 2 to 3 years). In contrast, population-based data
usually encompass multiple years and sometimes
explore decades of late outcome. Consequently, the
present population-based study not only confirms the
early benefits of carotid endarterectomy reported by
NASCET but also implies that the results can be repli-
cated in community patients treated by expert sur-
geons and are remarkably durable.
We gratefully acknowledge the additional statistical
assistance of Charles M. Rowland, MS, the methodologic
critique of Steven J. Jacobsen, MD, PhD, and the editor-
ial assistance of Renee Brandt.
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I have some questions for Dr. Hallett that concern this
study. First, the NASCET selected centers with skilled sur-
geons who had a rate of less than 6% for stroke and death
within 20 days of an operation. Dr. Hallett noted that the
perioperative stroke immortality rate was less than 6% at
the Mayo Clinic. One wonders whether these rates were
uniform among all the surgeons in the Mayo Clinic.
Second, the percent stenoses of carotid arteries was
carefully documented by neuroradiologists in the NASCET
study. In the manuscript, the percent of carotid stenoses in
patients in Olmsted County was not discussed. Did some of
your patients have ulcers, or did some patients have less than
50% stenoses?
Third, did all of your patients receive antiplatelet treat-
ment as the patients did in the NASCET study? If so, what
form of platelet inhibition do you prefer?
Fourth, the NASCET study excluded patients who did
not have angiographic visualization of the carotid arteries.
Did you perform carotid endarterectomy without
angiograms?
Fifth, please comment upon the type of anesthesia you
use. Our current choice is regional cervical block.
Your report not only confirms the recommendation of
NASCET for carotid endarterectomy for high-grade
symptomatic carotid stenosis but also demonstrates that
the beneficial results exist for at least 10 years. We thank
you for sharing these data from the Mayo Clinic with us.
Dr. John W. Hallett. Thank you, Dr. Silver.
Anticoagulation or antiplatelet therapy in the lesions includ-
ed in this study ranged from one baby aspirin a day to two
regular aspirin per day. Angiography was used in all of the
patients in this period of time. Although we use ultrasound
scan alone for asymptomatic patients in general, we have
used some type of arteriography, either intravenous, stan-
dard intraarterial, or magnetic resonance, for the evaluation
of these symptomatic patients before operation. General
anesthesia with electroencephalography monitoring has
been the standard at the clinic for over 25 years. All of the
patients in this study had that type of anesthesia.
DISCUSSION
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Dr. Donald Silver (Columbia, Mo.). I thoroughly
enjoyed this presentation by Dr. Hallett. In 1991, the
North American Symptomatic Carotid Endarterectomy
Trial (NASCET) reported results for a randomized trial
during which 659 patients who had hemispheric or retinal
ischemic attacks or nondisabling stroke within the previ-
ous 120 days and who had a 70% to 99% stenosis were
treated either medically or by carotid endarterectomy. The
results were so supportive of the benefits of the role of
carotid endarterectomy that the study was terminated
early. The study reported a 26% ipsilateral stroke rate in
the medical patients after 2 years and a 9% ipsilateral
stroke rate in the surgical patients. Fatal ipsilateral stroke
rates were 13% and 2.5%, respectively. The NASCET
report firmly established the beneficial role of carotid
endarterectomy for a symptomatic patient with carotid
stenosis.
Dr. Hallett and his colleagues at the Mayo Clinic have
presented review of all the patients in Olmsted County,
Minn. who had a carotid endarterectomy for TIA or dis-
abling stroke in the 25-year period between 1970 and
1995. All the carotid endarterectomies were performed at
the Mayo Clinic; 297 patients had 312 carotid endarterec-
tomies, and 85% of the patients had transient ischemic
attacks and nondisabling strokes. Survival without ipsilat-
eral stroke was 95% in 2 years, 92% in 5 years, and 90% in
10 years. The results (91% at 2 years) were similar to the
results of the NASCET study. The 30-day operative mor-
tality rate was 1.6% for the Mayo Clinic group. Stroke was
the cause of death in eight patients in the Mayo Clinic
group as compared with 13% for the NASCET patients.
Dr. Hallett and his colleagues have noted that hyper-
tension is a major risk factor that contributes to the
increased risk of transient ischemic attacks or stroke after
carotid endarterectomy. Diabetes and ischemic heart dis-
ease reduced the survival rate of their patients. This study
has been a long-term study of patients from a single com-
munity who had a carotid endarterectomy for transient
ischemic attacks or disabling stroke.
